RVPH READ THE FULL RVPH RESEARCH REPORT Operational and Financial Results On November 14th, 2024, Reviva Pharmaceutical ...

No approved drug in the U.S. has been able to fully address these symptoms. While second generation antipsychotics offer benefits, negative symptoms remain a major unmet need to provide comprehensive ...

A peptide hormone produced in the brain that triggers physiological reproductive responses has been 'hacked' by scientists to form an effective, safe and non-invasive way to treat chronic gut pain. It ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...

Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

Researchers explain how a drug that helps patients with neurological issues walk may also provide a surprising boost for the ...